Skip to content
DataInside
Platform
Solutions
Data and trust
Directory
Pricing
Developers
Sign in
Start free
DataInside
Platform
Company search and data
Find companies by what they do, where and who they work for
Contacts
In development
Business emails and phone numbers for the people who decide
Signals and intent
Contract awards, hiring, funding and leadership changes as they happen
Enrich
In development
Fill in and keep current the company records you already have
Assistant
In development
Ask questions about companies and get answers with their sources
Integrations and API
Your CRM, Slack and your own systems, through one set of rules
Browser extension
In development
Company facts beside any company website, CRM record or email
Website visitors
In development
See which companies are reading your site, and which pages
One record behind every module, with its source.
Platform overview
Solutions
Sales
Build pipeline from accounts that are ready to buy
Marketing
Target accounts, enrich sign-ups and see who's on your site
Revenue operations
Keep CRM data complete, current and within the rules
Recruiting
Find growing companies and the teams that are hiring
Government market
Federal contractors, agencies and awards, from official records
Data and trust
Directory
Pricing
Developers
Sign in
Loading company…
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH: federal contract awards | DataInside
← Search
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
1 new award on record, $733,525 obligated.
Sign in to save this company to a list
Company facts
Name
RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
Reported to the government
Source:
USAspending.gov awards
(opens in a new tab)
Collected 2026-11-14
Unique Entity ID (UEI)
JMW6R9VB27L9
Reported to the government
Source:
USAspending.gov awards
(opens in a new tab)
Collected 2026-11-14
Contract awards
Award
Agency
Industry (NAICS)
Obligated (USD)
Signed
75F40126C00098
on USAspending.gov (opens in a new tab)
Food and Drug Administration
541714
research and development in biotechnology (except nanobiotechnology)
$733,525
2026-09-04